过去一年中添加的文章,按日期排序

The role of osteopontin and osteocyte-derived factors in secondary hyperparathyroidism-induced myopathy

EJ Duque, SF Crispilho, IB Oliveira, WV Dominguez… - JBMR Plus, 2024 - academic.oup.com
4 天前 - bone histomorphometry have been analyzed previously.(17) Studies have shown
that bone turnover … on the biology of bone tissue in patients with chronic kidney disease and …

Corrigendum:[Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD-MBD Model Rats by Targeting …

BH Liu, FL Chong, CC Yuan, YL Liu, HM Yang… - Frontiers in … - frontiersin.org
7 天前 - Frontiers | Corrigendum: [Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus
Metabolic Disorder and Bone Abnormality in the CKD-MBD Model Rats by …

Advanced glycosylation end products promote the progression of CKD-MBD in rats, and its natural inhibitor, quercetin, mitigates disease progression

Y Wang, C Hu, L Cao, Q Liu, Y Li, T Zhu… - … Archives of Pharmacology, 2024 - Springer
9 天前 - Chronic kidney disease–mineral and bone metabolism disorder (CKD-MBD) is a
common chronic kidney disease … Effects of quercetin on renal function, renal pathology and …

Current therapeutic approach of chronic kidney disease‐mineral and bone disorder

M Zaimi, E Grapsa - Therapeutic Apheresis and Dialysis, 2024 - Wiley Online Library
12 天前 - Bone metabolism markers Albeit bone biopsy with … standard for bone turnover
evaluation and bone pathology … on kidney clearance and does not impact kidney function [129]. A …

[PDF][PDF] The Pathway Towards a Reference Measurement Procedure for 1-84 Parathyroid Hormone. An intact protein analysis approach by LC-MS/MS.

J Farre Segura - 2024 - orbi.uliege.be
12 天前 - … in bone turnover, however, a so-called “anabolic window” is observed, where bone
formation … nowadays established as the IFCC Committee on Bone Metabolism, whose main …

Ganoderma pfeifferi Bres. 1889 and Ganoderma resinaceum Boud. 1889 as Potential Therapeutic Agents: A Comparative Study on Antiproliferative and Lipid …

M Rašeta, M Kebert, J Mišković, S Kostić, S Kaisarevic… - 2024 - preprints.org
13 天前 - … in the human body like bone health and muscle and nerve function, with calcium
(Ca … on white Wistar rats by preservation of kidney function parameters in G. resinaceum H2O …

Sex-Related Determinants of Exercise Intolerance in HFpEF: Not Just a Matter of the Heart!

L Del Punta, N De Biase, NR Pugliese - JACC: Advances, 2024 - jacc.org
18 天前 - disease, and chronic kidney disease. However, multiple diverse pathophysiologic
derangements seem to delineate different HFpEF subphenotypes, including impaired systolic …

Identification of novel risk factors for postoperative severe hypocalcemia in patients with primary hyperparathyroidism undergoing parathyroidectomy: a case control …

J Xu, N Kong, N Bai, Z Zhang, A Cui, S Tan… - … Endocrine Disorders, 2024 - Springer
19 天前 - … , bone turnover markers, and renal function parameters were … bone syndrome is
found typically in patients with severe PHPT and preoperative high bone turnover or in renal

THE INFLUENCE OF LOCAL IMMUNE SYSTEM FACTORS ON THE DEVELOPMENT OF ORAL DISEASES IN PATIENTS WITH CHRONIC RENAL FAILURE

JA Rizayev, FA Husanbaeva - World Bulletin of Public Health, 2024 - scholarexpress.net
20 天前 - … The prevalence of chronic kidney disease in industrialised countries is constantly
… between patients with chronic kidney disease and patients with chronic renal failure. In …

[PDF][PDF] Short-Term Effects of dapagliflozin on biomarkers of bone and mineral metabolism in patients with diabetic kidney disease: A prospective observational study

T Islek, S Mirioglu, M Gursu, R Kazancioglu… - …, 2024 - revistanefrologia.com
20 天前 - … to determine whether SGLT-2i affect bone metabolism. … with a decline in kidney
function. Both markers were found … Mineral and bone disorders in chronic kidney disease: new …